Search clinical trials for: SyB V-1901

Total 3179 results

SymBio Pharmaceuticals

Recruiting

Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation

BK Virus Infection | Kidney Transplantation | Nephropathy

Australia, Japan
SymBio Pharmaceuticals

Terminated

Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain

Postoperative Pain

Japan
Vicept Therapeutics, Inc.
Accenture

Completed

Dose Response Study of Patients With Erythematous Rosacea

Erythematous (Type One) Rosacea

United States
TG Therapeutics, Inc.

Active, not recruiting

Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia

Follicular Lymphoma | Marginal Zone Lymphoma | DLBCL | CLL | MCL | Indolent Lymphoma | Richter's Transformation | SLL | Mediastinal Large B-cell Lymphoma | Aggressive Lymphoma

United States
SymBio Pharmaceuticals

Completed

Study of SyB C-1101 in Patients With Myelodysplastic Syndrome

Myelodysplastic Syndrome

Japan
SymBio Pharmaceuticals

Completed

Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects

Drug Drug Interaction

Japan
SymBio Pharmaceuticals

Completed

Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome

Japan
SymBio Pharmaceuticals

Completed

Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome

Japan
SymBio Pharmaceuticals

Completed

Long Term Safety Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study

Myelodysplastic Syndrome

Japan
SymBio Pharmaceuticals

Completed

Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study

Myelodysplastic Syndrome

Japan
IlDong Pharmaceutical Co Ltd

Completed

A Drug Interaction Study of Cilnidipine and Valsartan

Healthy

Korea, Republic of
Livzon Pharmaceutical Group Inc.

Active, not recruiting

A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5 (COVID-19)

COVID-19 Pandemic

China
SymBio Pharmaceuticals

Completed

Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

Japan
Apollomics Inc.

Recruiting

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)

Gastric Cancer | Pancreatic Cancer | NSCLC | Lung Cancer | Brain Tumor | Glioblastoma Multiforme | Advanced Cancer | Colon Cancer | Solid Tumors | Thyroid Cancer | Renal Cancer | Gastroesophageal Junction Adenocarcinoma | EGFR Gene Mutation | MET Amplification | HGF | MET Alteration | MET Fusion | Exon 14 Skipping

United States, Spain, France, United Kingdom, Taiwan, Australia, Finland, Italy, Singapore, Hungary, Canada, Puerto Rico, Russian Federation
The Royal Bournemouth Hospital

Completed

R-wave Optimisation in Cardiac Resynchronisation Therapy Study

Heart Failure, Systolic

United Kingdom
Immunitor LLC

Unknown

V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer (GBM)

Glioblastoma Multiforme | Glioma of Brain

Mongolia
Inossia AB
Uppsala University; EIT Health

Recruiting

Investigating Bone Cement With or Without Inossia™ Cement Softener for Vertebral Compression Fractures (SOFTBONE)

Vertebral Compression Fracture

Spain, Germany, Canada, Poland
SN BioScience

Not yet recruiting

Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors

Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Small-cell Lung Cancer | Pancreas Cancer

Korea, Republic of
SymBio Pharmaceuticals

Withdrawn

Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome

Myelodysplastic Syndrome

Japan
SymBio Pharmaceuticals

Completed

Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Japan
PepTcell Limited

Completed

Phase 1b Influenza Vaccine Study in Healthy Subjects

Influenza

United Kingdom
Hemotek Medical Inc
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Confirmatory Study to Assess the V Needle in End-Stage Renal Disease Patients During In-Clinic Hemodialysis (Clinic-SAVER)

End Stage Renal Disease

United States
Oregon Research Institute

Recruiting

Virtual Tai ji Quan Exercise to Prevent Falls in Older Adults

Accidental Fall

United States
Stallergenes Greer
Quintiles, Inc.

Completed

Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1

Rhinitis, Allergic, Seasonal | Birch Pollen-Related Rhinoconjunctivitis

Denmark
TG Therapeutics, Inc.

Completed

Study of TG-1801 in Subjects With B-Cell Lymphoma

B-Cell Lymphoma

Australia
Ain Shams Maternity Hospital

Completed

Use of v Care in Abdominal Hysterectomy

Uterine Fibroid

Egypt
Brainvectis, a subsidiary of Asklepios BioPharmaceutical...

Active, not recruiting

A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease

Huntington Disease

France
SymBio Pharmaceuticals

Completed

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Radiotherapy-induced Nausea and Vomiting (RINV)

Japan
Stallergenes Greer
Quintiles, Inc.

Completed

Safety and Tolerability Study of rBet v1 SLIT Tablets

Rhinitis, Allergic, Seasonal | Birch Pollen-Related Rhinoconjunctivitis

Denmark
TG Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center

Completed

Study of Immunotherapy in Combination With Ublituximab and Umbralisib in Patients With Relapsed-refractory CLL or Richter's Transformation

Chronic Lymphocytic Leukemia | Richter Syndrome

United States
CellabMED
Yooyoung Pharmaceutical Co., Ltd.

Completed

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients

Colorectal Cancer Metastatic | Colorectal Cancer Recurrent

Korea, Republic of
Stallergenes Greer
Quintiles, Inc.; Aptuit

Completed

Study of rBet v1 Tablets

Rhinitis, Allergic, Seasonal | Birch Pollen-related Rhinoconjunctivitis

Denmark, Finland, France, Poland, Germany, Lithuania, Russian Federation, Sweden
Onconova Therapeutics, Inc.

Completed

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Cytopenia | Refractory Anemia With Excess Blasts

United States, Australia, Spain, Italy, Germany, France, Sweden, Denmark
Gilead Sciences

Terminated

Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies

Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Indolent Non-Hodgkin's Lymphoma

United States
PepTcell Limited

Completed

HIV Vaccine Study in HIV Positive Patients

HIV Infections

United Kingdom
Samyang Biopharmaceuticals Corporation

Not yet recruiting

A Study Comparing SYB PDO Thread and MINT Lift® for Temporary Nasolabial Fold Improvement

Nasolabial Folds
The Advanced Gynecologic Surgery Institute
Medtronic - MITG

Withdrawn

a Study to Evaluate Adhesion Risk in Fertility Patients' Status Post Laparoscopic Myomectomy. (VLocmyo)

Infertility | Uterine Fibroids

United States
US Department of Veterans Affairs

Unknown

VISN 23 Chronic Obstructive Pulmonary Disease (COPD) Case Management Using Home Telehealth Equipment

COPD

United States
Jonsson Comprehensive Cancer Center

Active, not recruiting

Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules

Thyroid

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of a First-in-Human Mosquito Saliva Peptide Vaccine

Mosquito-Borne Disease

United States
Medical University of Vienna

Unknown

Postoperative Atrial Fibrillation Suppression By Nerve Stimulation

Atrial Fibrillation
CellabMED

Completed

Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy

Solid Tumors

Korea, Republic of
TG Therapeutics, Inc.

Active, not recruiting

Study of TG-1701, an Irreversible Bruton's Tyrosine Kinase Inhibitor, in Patients With B-Cell Malignancies

Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma

Australia, Poland
Todos Medical, Ltd.

Completed

Effect of Daily Oral Administration of Food Supplement NLC-V in Patients Diagnosed With COVID-19

COVID-19

Israel
Immunitor LLC
Ekomed LLC

Unknown

Open Label Immunotherapy of Endometriosis

Endometriosis

Mongolia
Crucell Holland BV

Completed

Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V

Influenza

Italy
Hyprevention

Completed

The Purpose of This Study is to Evaluate Safety and Performance of the V-STRUT© Transpedicular Vertebral System

Vertebral Compression Fracture

France
William Beaumont Hospitals

Terminated

Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2

Severe Acute Respiratory Syndrome | COVID-19 | SARS-COV2

United States
V-Wave Ltd

Withdrawn

Heart Failure (HF) Interatrial Shunt Study 1

Chronic Heart Failure

Israel
Samyang Biopharmaceuticals Corporation

Completed

A Study to Evaluate the Safety and Efficacy of SYB Filler(SF-01) in the Correction of Nasolabial Folds

Nasolabial Folds

Korea, Republic of

Search clinical trials for: SyB V-1901

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations